Cunha Ferreira C, Machado Soares R, Fernandes J, Teixeira S, Saraiva E, Ribeiro L
J Ophthalmic Vis Res. 2024; 19(3):324-333.
PMID: 39359524
PMC: 11443993.
DOI: 10.18502/jovr.v19i3.13531.
Vitiello L, Lixi F, Coppola A, Abbinante G, Gagliardi V, Salerno G
J Clin Med. 2024; 13(17).
PMID: 39274219
PMC: 11395781.
DOI: 10.3390/jcm13175006.
Munk M, Ceklic L, Stillenmunkes R, Chaudhary V, Waheed N, Chhablani J
Diagnostics (Basel). 2024; 14(17).
PMID: 39272767
PMC: 11394301.
DOI: 10.3390/diagnostics14171983.
Tan T, Ibrahim F, Chandrasekaran P, Teo K
Front Med (Lausanne). 2023; 10:1110166.
PMID: 37359003
PMC: 10285461.
DOI: 10.3389/fmed.2023.1110166.
Campochiaro P
Eye (Lond). 2023; 37(16):3302-3303.
PMID: 37277613
PMC: 10630400.
DOI: 10.1038/s41433-023-02596-8.
Visual Prognostic Factors in Eyes with Subretinal Fluid Associated with Branch Retinal Vein Occlusion.
Sasajima H, Zako M, Murotani K, Ishida H, Ueta Y, Tachi N
J Clin Med. 2023; 12(8).
PMID: 37109246
PMC: 10146202.
DOI: 10.3390/jcm12082909.
Current Best Clinical Practices-Management of Retinal Vein Occlusion.
Modi Y, Klufas M, Sridhar J, Singh R, Yonekawa Y, Pecen P
J Vitreoretin Dis. 2023; 4(3):214-219.
PMID: 37007445
PMC: 9982258.
DOI: 10.1177/2474126420906395.
Effects of Ranibizumab combined with laser photocoagulation on macular volume and best corrected visual acuity in patients with macular edema secondary to ischemic retinal vein occlusion.
Liang J, Xiong T, Chen H, Tao R, Cao L
Pak J Med Sci. 2023; 39(2):385-389.
PMID: 36950445
PMC: 10025720.
DOI: 10.12669/pjms.39.2.7040.
Comparison of Intravitreal Dexamethasone Implant and Intravitreal Ranibizumab Efficacy in Younger Patients with Branch Retinal Vein Occlusion.
Ozcift S, Aydin E, Egrilmez E, Koc F, Eris E
Beyoglu Eye J. 2023; 8(1):21-25.
PMID: 36911221
PMC: 9993420.
DOI: 10.14744/bej.2023.42243.
Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide.
McAllister I, Vijayasekaran S, Bhikoo R, Chen F, Zhang D, Kanagalingam E
Transl Vis Sci Technol. 2023; 12(2):11.
PMID: 36753186
PMC: 9919627.
DOI: 10.1167/tvst.12.2.11.
Therapeutic Effects of Combination Therapy and Photobiomodulation Therapy on Retinal Regeneration.
Ahrabi B, Omidvari S, Ghomi S, Roozbahany N, Vafaei-Nezhad S, Shirazi Tehrani A
J Lasers Med Sci. 2023; 13:e36.
PMID: 36743147
PMC: 9841384.
DOI: 10.34172/jlms.2022.36.
Long-term real-world outcomes in retinal vein occlusions: How close are we to the trials?.
Shah P, Shanmugam M, Vora U, Agrawal S, Sirivella I, Suryakanth S
Indian J Ophthalmol. 2022; 70(12):4370-4375.
PMID: 36453347
PMC: 9940561.
DOI: 10.4103/ijo.IJO_1330_22.
Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to or Treat-and-Extend Regimen in Eyes with or without Epiretinal Membrane.
Hamam M, Lagali N, Abdulnour E, Setterud H, Johansson B, Mirabelli P
J Ophthalmol. 2022; 2022:6288582.
PMID: 36225608
PMC: 9550471.
DOI: 10.1155/2022/6288582.
Wide-field swept-source OCT angiography of the periarterial capillary-free zone before and after anti-VEGF therapy for branch retinal vein occlusion.
Tang W, Liu W, Guo J, Zhang L, Xu G, Wang K
Eye Vis (Lond). 2022; 9(1):25.
PMID: 35778771
PMC: 9250258.
DOI: 10.1186/s40662-022-00297-z.
Foveal Intraretinal Fluid Localization Affects the Visual Prognosis of Branch Retinal Vein Occlusion.
Sasajima H, Zako M, Maeda R, Murotani K, Ishida H, Ueta Y
J Clin Med. 2022; 11(12).
PMID: 35743609
PMC: 9224585.
DOI: 10.3390/jcm11123540.
Navigated laser and aflibercept versus aflibercept monotherapy in treatment-naïve branch retinal vein occlusion: A 12-month randomized trial.
Frederiksen K, Vestergaard J, Pedersen F, Vergmann A, Sorensen T, Laugesen C
Acta Ophthalmol. 2022; 100(7):e1503-e1509.
PMID: 35611568
PMC: 9790367.
DOI: 10.1111/aos.15182.
Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion.
Scott I, VanVeldhuisen P, Oden N, Ip M, Blodi B
Am J Ophthalmol. 2022; 240:330-341.
PMID: 35461831
PMC: 11064059.
DOI: 10.1016/j.ajo.2022.04.001.
A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion.
Bayat A, Bolukbasi S, Erden B, Cakir A, Ozturan S, Tayfur M
Beyoglu Eye J. 2022; 4(3):131-135.
PMID: 35187448
PMC: 8842062.
DOI: 10.14744/bej.2019.18291.
Effects of the epiretinal membrane on the outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion.
Kocak Altintas A, Ilhan C
Arq Bras Oftalmol. 2022; 86(1):13-19.
PMID: 35170657
PMC: 11826661.
DOI: 10.5935/0004-2749.20230011.
Impact of serous macular detachment on visual recovery in retinal vein occlusion treatment.
Firat I, Polat N, Firat M
Arq Bras Oftalmol. 2022; 85(6):606-613.
PMID: 35170645
PMC: 11826692.
DOI: 10.5935/0004-2749.20220088.